Kategorija: Novice

Družba Wave Life Sciences napoveduje pozitivne rezultate preskušanja faze 1b/2a SELECT-HD s prvim kliničnim dokazom alelno selektivnega znižanja vrednosti mutiranega huntingtina pri Huntingtonovi bolezni

Today, Wave Life Sciences announced positive results from SELECT-HD, our Phase 1b/2a placebo-controlled trial evaluating the investigational therapy WVE-003. These results demonstrate that WVE-003 selectively lowers toxic, mutant huntingtin (mHTT) […]

Družba PTC je danes objavila obetavne 12-mesečne rezultate študije faze 2 PIVOT-HD o peroralnem zdravilu PTC518.  

At Month 12, mutant Huntingtin (mHTT) in the blood was lowered by 22% and 43% respectively for 5mg and 10mg doses. A similar result was seen in cerebrospinal fluid, where […]

Študija 2. faze družbe Sage Therapeutics potrjuje kognitivni vpliv Huntingtonove bolezni

Earlier this week Sage Therapeutics announced the results of their SURVEYOR study which quantified the cognitive impact of Huntington’s Disease.  Using the HD-Cognitive Assessment Battery (HD-CAB) they measured the difference […]

Novosti z Bližnjega vzhoda in severne Afrike

IHA President Svein Olaf Olsen was keynote speaker on Huntington’s Disease at the MENA Congress for Rare Diseases in Abu Dhabi last month. He spoke of the urgent need to […]

FDA podeljuje podjetju uniQure naziv napredne terapije regenerativne medicine (RMAT)

Today we are very happy in the Huntington community.  The announcement from Uniqure that the company has received the Regenerative Medicine Advanced Therapy (RMAT) “Designation for Investigational Gene Therapy AMT-130 […]

Brezplačni spletni program psihoterapije za osebe s težavami s HD

Doctors at the University of Reading (UK) have developed a free online psychotherapy programme for people with Huntington’s Disease.  It’s part of a research project that looks at how people […]

V Pakistanu financirajo novo združenje za Huntingtonovo bolezen - HDSOP

Founding of the Huntington’s Disease Society of Pakistan April 24th 2024 Last week another national association was created.  The Huntington’s Disease Society of Pakistan (HDSOP) joined the growing  list of […]

Družba SOM Biotech zaključuje postopek nabora v študijo faze IIb zdravljenja koreje pri Huntingtonovi bolezni

Podjetje SOM Biotech, ki se ukvarja z odkrivanjem in razvojem zdravil v klinični fazi in temelji na edinstveni lastni platformi umetne inteligence (SOMAIPRO®), z veseljem sporoča, da je nabor v klinično raziskavo faze IIb, v kateri je sodeloval tudi [...]

Prilenia namerava v EU vložiti vlogo za pridobitev dovoljenja za promet za pridopidin pri Huntingtonovi bolezni

Prilenia announced today that they plan to submit a Marketing Authorization Application in the EU for the use of Pridopidine in the treatment of Huntington’s Disease. According to Dr. Michael […]

Odkritje predstavlja novo upanje za bolnike s HD

Scientists from the Weizmann Institute in Israel have published the results of an animal study which holds tremendous promise for the treatment of Huntington’s Disease.  They have discovered that two […]